Dr. Martens (LON:DOCS) Shares Up 25.8% - What's Next?

Dr. Martens plc (LON:DOCS - Get Free Report) was up 25.8% during trading on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). Approximately 8,364,149 shares traded hands during mid-day trading, an increase of 271% from the average daily volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).

Analysts Set New Price Targets

Separately, Royal Bank of Canada dropped their price objective on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a research note on Monday, May 19th.

Dr. Martens Stock Performance

The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The stock has a 50-day moving average of GBX 54.73 and a 200 day moving average of GBX 62.64. The stock has a market cap of £795.54 million, a PE ratio of 11.62, a P/E/G ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Equities analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Dr. Martens Cuts Dividend

The firm also recently announced a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens's dividend payout ratio (DPR) is 42.53%.

Insider Activity

In related news, insider Giles Wilson acquired 32,640 shares of the firm's stock in a transaction dated Tuesday, March 25th. The shares were purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). Insiders have acquired a total of 33,206 shares of company stock valued at $1,792,771 in the last quarter. Insiders own 4.36% of the company's stock.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.